Details of the Drug

General Information of Drug (ID: DMZDPEF)

Drug Name

OrthoDerm

Synonyms

Methyl 3-amino-4-hydroxybenzoate; 536-25-4; Orthocaine; Orthoform; Aminobenz; Orthoderm; 3-Amino-4-hydroxybenzoic acid methyl ester; BENZOIC ACID, 3-AMINO-4-HYDROXY-, METHYL ESTER; Methyl m-amino-p-hydroxybenzoate; Methyl 4-hydroxy-3-aminobenzoate; UNII-JK16YI13QK; NSC 9813; Methyl 3-amino-4-hydroxybenzenecarboxylate; EINECS 208-627-3; BRN 0608715; JK16YI13QK; AI3-04738; Mehyl3-amino-4-hydroxybenzoate; Methyl-3-amino-4-hydroxybenzoate; VNQABZCSYCTZMS-UHFFFAOYSA-N; methyl 3-amino-4-hydroxy-benzoate; 3-AMINO-4-HYDROXY-BENZOIC ACI

Indication

Disease Entry	ICD 11	Status	REF
Musculoskeletal disorder	FA00-FC0Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C8H9NO3
Canonical SMILES: COC(=O)C1=CC(=C(C=C1)O)N
InChI: 1S/C8H9NO3/c1-12-8(11)5-2-3-7(10)6(9)4-5/h2-4,10H,9H2,1H3
InChIKey: VNQABZCSYCTZMS-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 10815
ChEBI ID: CHEBI:34904
CAS Number: 536-25-4
TTD ID: D02WRV

References

1	ClinicalTrials.gov (NCT00447928) Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow. U.S. National Institutes of Health.